HI
BBIO icon

Handelsinvest Investeringsforvaltning’s BridgeBio Pharma BBIO Stock Holding History

Handelsinvest Investeringsforvaltning’s Portfolio BBIO Stock Details BBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		$151K Sell
4,886
-2,537
-34% -$86.3K 0.07% 302
2023
Q4 		$300K Buy
+7,423
New +$223K 0.12% 263

Other funds holding BBIO

KKRC
Kohlberg Kravis Roberts & Co New York $5.35B AUM 63.01% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACM
Aisling Capital Management New York $476M AUM 128.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Handelsinvest Investeringsforvaltning's BBIO Position: Q1 2024 in Review

Handelsinvest Investeringsforvaltning reduced its BridgeBio Pharma (BBIO) stake by 34% in Q1 2024, selling an estimated $86.3K and leaving 4,886 shares worth $151K. The position accounts for 0.07% of the portfolio, ranked #302.

Handelsinvest Investeringsforvaltning first reported a position in BBIO in Q4 2023 and has held it in 2 quarters since. The position peaked at $300K in Q4 2023. 244 funds tracked by Wall St. Rank hold BBIO as of Q1 2024.

  • Handelsinvest Investeringsforvaltning held 4,886 shares of BridgeBio Pharma worth $151K as of Q1 2024.
  • Handelsinvest Investeringsforvaltning sold 2,537 BridgeBio Pharma shares in Q1 2024, an estimated $86.3K.
  • BridgeBio Pharma made up 0.07% of Handelsinvest Investeringsforvaltning's portfolio in Q1 2024, its #302 holding.
  • Handelsinvest Investeringsforvaltning first reported a position in BridgeBio Pharma in Q4 2023 and has held it in 2 quarters since.
  • Handelsinvest Investeringsforvaltning's BridgeBio Pharma position peaked at $300K in Q4 2023.
  • 244 funds tracked by Wall St. Rank held BridgeBio Pharma as of Q1 2024.

Based on Handelsinvest Investeringsforvaltning's 13F filing for Q1 2024, filed 19 Apr 2024.